These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9890315

  • 1. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
    J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
    [Abstract] [Full Text] [Related]

  • 2. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
    Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [Abstract] [Full Text] [Related]

  • 4. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y, Nakanishi K, Kamei K, Togawa H, Nozu K, Tanaka R, Sasaki S, Iijima K, Yoshikawa N.
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
    Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
    Yoshikawa N, Ito H.
    Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
    [No Abstract] [Full Text] [Related]

  • 8. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 9. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
    [Abstract] [Full Text] [Related]

  • 10. Glomerular electron-dense deposits in childhood IgA nephropathy.
    Yoshikawa N, Ito H, Nakahara C, Yoshiara S, Yoshiya K, Matsuo T, Hasegawa O, Hazikano H, Okada S.
    Virchows Arch A Pathol Anat Histopathol; 1985 Aug; 406(1):33-43. PubMed ID: 3158115
    [Abstract] [Full Text] [Related]

  • 11. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 12. Mesangial C4d Deposits in Early IgA Nephropathy.
    Segarra A, Romero K, Agraz I, Ramos N, Madrid A, Carnicer C, Jatem E, Vilalta R, Lara LE, Ostos E, Valtierra N, Jaramillo J, Arredondo KV, Ariceta G, Martinez C.
    Clin J Am Soc Nephrol; 2018 Feb 07; 13(2):258-264. PubMed ID: 29146701
    [Abstract] [Full Text] [Related]

  • 13. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
    Moriya T, Nakazawa K, Itoh N, Shigematsu H, Higuchi M, Miyasaka M, Oguchi H.
    Nihon Jinzo Gakkai Shi; 1992 Apr 07; 34(4):423-30. PubMed ID: 1635288
    [Abstract] [Full Text] [Related]

  • 14. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
    Nihon Jinzo Gakkai Shi; 1994 Jan 07; 36(1):38-43. PubMed ID: 8107307
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.
    Wada Y, Ogata H, Takeshige Y, Takeshima A, Yoshida N, Yamamoto M, Ito H, Kinugasa E.
    Clin Exp Nephrol; 2013 Feb 07; 17(1):73-82. PubMed ID: 22752397
    [Abstract] [Full Text] [Related]

  • 16. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Feb 07; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
    Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I.
    Int Urol Nephrol; 2002 Feb 07; 33(1):167-71. PubMed ID: 12090325
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec 07; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 19. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
    Clin Exp Nephrol; 2003 Mar 07; 7(1):48-51. PubMed ID: 14586743
    [Abstract] [Full Text] [Related]

  • 20. Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy.
    Valentijn RM, Radl J, Haayman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, van Es LA.
    Contrib Nephrol; 1984 Mar 07; 40():87-92. PubMed ID: 6499467
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.